• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Hemolytic-uremic syndrome in children and arterial hypertension].

作者信息

Habib R, Gagnadoux M F, Broyer M

出版信息

Arch Mal Coeur Vaiss. 1981 Jun;74 Spec No:37-43.

PMID:6794528
Abstract

Seventy patients (55 infants and 15 children) with the hemolytic uremic syndrome (HUS) were reviewed to evaluate the incidence of hypertension in HUS. Refractory hypertension was only observed in 5 infants (3 at onset and 2 after several months), whereas it was present in 9 children (4 at onset and 5 in the course of the disease). Controllable hypertension was present in 10 patients (8 infants and 2 children). Histopathological examination of renal specimens in 52 patients showed 3 patterns: cortical necrosis in 10, Thrombotic microangiopathy (TMA) with predominant glomerular involvement in 29 and TMA with predominant arterial involvement in 13. Clinicopathologic correlations showed that severe hypertension was almost exclusively observed in the patients with "vascular TMA". Bilateral nephrectomy performed in 8 patients led to the rapid disappearance of hypertension, thus demonstrating the role of hyperreninaemia in the development of hypertension in the HUS.

摘要

相似文献

1
[Hemolytic-uremic syndrome in children and arterial hypertension].
Arch Mal Coeur Vaiss. 1981 Jun;74 Spec No:37-43.
2
Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.溶血尿毒综合征(HUS):15例临床病理研究
Turk J Pediatr. 1993 Jan-Mar;35(1):23-36.
3
Prognosis and pathological characteristics of five children with non-Shiga toxin-mediated hemolytic uremic syndrome.
Pediatr Int. 2007 Apr;49(2):196-201. doi: 10.1111/j.1442-200X.2007.02352.x.
4
Intraplatelet serotonin (I5HT) in children with the hemolytic uremic syndrome.溶血尿毒综合征患儿的血小板内5-羟色胺(I5HT)
Clin Nephrol. 1985 Apr;23(4):207-11.
5
Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.儿童溶血尿毒综合征的长期(15 - 25年)预后
Clin Nephrol. 1996 Jul;46(1):39-41.
6
Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.溶血尿毒综合征患者的肾移植:高复发率及急性排斥反应发生率增加
Transplantation. 2003 Sep 15;76(5):821-6. doi: 10.1097/01.TP.0000085083.74065.1B.
7
[Hemolytic-uremic syndrome in children: a 19-year retrospective study].[儿童溶血尿毒综合征:一项19年的回顾性研究]
Schweiz Med Wochenschr. 1993 Jul 24;123(29):1439-44.
8
Postrenal transplant hemolytic uremic syndrome/thrombotic microangiopathy: Ahmedabad experience.肾移植后溶血性尿毒症综合征/血栓性微血管病:艾哈迈达巴德经验
Transplant Proc. 2008 May;40(4):1114-6. doi: 10.1016/j.transproceed.2008.03.028.
9
Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome.非典型溶血尿毒综合征患儿肾脏病理结果的预后价值
Iran J Kidney Dis. 2011 Nov;5(6):380-5.
10
Renal histopathology in the hemolytic-uremic syndrome following shigellosis.志贺菌病后溶血尿毒综合征的肾脏组织病理学
Clin Nephrol. 1984 Feb;21(2):126-33.

引用本文的文献

1
Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy.补体介导性血栓性微血管病的肾病理评分系统的临床价值。
Ren Fail. 2023 Dec;45(1):2161396. doi: 10.1080/0886022X.2022.2161396.
2
Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征的恶性高血压中靶向肾素-血管紧张素系统。
Indian J Nephrol. 2017 Mar-Apr;27(2):136-140. doi: 10.4103/0971-4065.181462.
3
Guidelines for the management and investigation of hemolytic uremic syndrome.
溶血性尿毒症综合征的管理与调查指南。
Clin Exp Nephrol. 2014 Aug;18(4):525-57. doi: 10.1007/s10157-014-0995-9.
4
[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].一名42岁双侧失明且患有高血压的患者。吉西他滨相关性血栓性微血管病(TMA)
Internist (Berl). 2008 Aug;49(8):989-90, 992-4. doi: 10.1007/s00108-008-2123-y.